食品科学 ›› 2025, Vol. 46 ›› Issue (23): 31-40.doi: 10.7506/spkx1002-6630-20250422-181

• 食用菌功能多组学技术挖掘与应用专栏 • 上一篇    

美味牛肝菌提取物对葡聚糖硫酸钠诱导小鼠肠炎的缓解作用及机制

常国飞,施筱钰,成琴,曾蓉烨,陈恬祯,黄开兰,张明,张秀清,马啸   

  1. (1.云南农业大学食品科学技术学院,云南 昆明 650201;2.中国农业大学理学院,北京 100193;3.中国农业大学食品科学与营养工程学院,北京 100193;4.云南农业大学 云南省高原特色农业产业研究院,云南省生物大数据重点实验室,云南 昆明 650201)
  • 发布日期:2025-12-26
  • 基金资助:
    云南省科技计划项目-农业联合专项(202301BD070001-195);云南省兴滇英才青年人才专项(YNWR-QNBJ2018-173)

Alleviating Effect and Mechanism of Boletus edulis Extract on Dextran Sodium Sulfate-Induced Enteritis in Mice

CHANG Guofei, SHI Xiaoyu, CHENG Qin, ZENG Rongye, CHEN Tianzhen, HUANG Kailan, ZHANG Ming, ZHANG Xiuqing, MA Xiao   

  1. (1. College of Food Science and Technology, Yunnan Agricultural University, Kunming 650201, China;2. College of Science, China Agricultural University, Beijing 100193, China;3. College of Food Science & Nutritional Engineering, China Agricultural University, Beijing 100193, China;4. Yunnan Plateau Characteristic Agricultural Industry Research Institute, Yunnan Provincial Key Laboratory of Biological Big Data, Yunnan Agricultural University, Kunming 650201, China)
  • Published:2025-12-26

摘要: 通过葡聚糖硫酸钠诱导肠炎模型,结合超高效液相色谱-串联质谱、多组学联合分析、分子对接以及网络药理学等方法深入探讨美味牛肝菌提取物对肠道炎症的缓解作用及其机制。结果显示,通过超高效液相色谱-串联质谱技术和多组学数据库的综合分析、鉴定美味牛肝菌提取物中的活性成分及其潜在作用靶点;通过网络药理学方法对这些活性成分的作用靶点进行预测,并筛选出美味牛肝菌在炎症性肠病中的潜在靶点;通过构建化合物-靶点相互作用网络和蛋白-蛋白相互作用网络,识别出了如AKT1、TNF等关键靶基因;基因本体论和京都基因与基因组百科全书的分析表明,美味牛肝菌的活性成分可能通过影响包括核因子-κB(nuclear factor-kappa B,NF-κB)信号通路在内的多个炎症相关信号通路发挥抗炎作用;分子对接研究结果进一步证实了美味牛肝菌中活性成分与炎症相关分子的相互作用,并揭示了美味牛肝菌中Emeheterone对炎症性肠病的抗炎作用尤为显著。此外,通过过碘酸-雪夫氏染色分析葡聚糖硫酸钠诱导的小鼠,证实美味牛肝菌能显著恢复肠道黏蛋白的表达;血液代谢组学分析揭示了美味牛肝菌可能通过改善色氨酸代谢、酪氨酸代谢等途径改善葡聚糖硫酸钠诱导的全身性代谢紊乱。综上所述,美味牛肝菌提取物可能通过抑制NF-κB等炎症信号通路修复肠道黏膜屏障。非靶向代谢组学结果表明,美味牛肝菌提取物可通过调节色氨酸、氨基酸代谢等途径有效改善葡聚糖硫酸钠诱导的小鼠血液代谢紊乱,恢复机体代谢稳态。总体来看,美味牛肝菌提取物可作为一种天然多靶点干预肠道炎症的策略,在炎症性肠病预防和治疗中具有潜在应用价值,为开发新型肠道健康干预方案提供了理论依据。

关键词: 美味牛肝菌提取物;炎症性肠病;核因子-κB信号通路;代谢组学

Abstract: This study systematically investigated the alleviating effect and underlying mechanism of Boletus edulis extract on dextran sodium sulfate-induced enterocolitis in mice. An integrated approach combining ultra-high performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), multi-omics analysis, molecular docking, and network pharmacology was employed. The results showed that the active components of B. edulis extract and their potential targets were identified by UPLC-MS/MS and comprehensive analysis of multi-omics database. The targets of these active ingredients were predicted by network pharmacology and screened for potential targets of B. edulis against inflammatory bowel disease. By constructing compound-target interaction networks and protein-protein interaction networks, key target genes such as AKT1 and TNF were identified. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses indicated that the active components of B. edulis exerted anti-inflammatory effects by affecting several inflammation-related signaling pathways including the nuclear factor-kappa B (NF-κB) signaling pathway. Molecular docking studies further confirmed the interaction of the active ingredients in B. edulis with inflammation-related molecules and revealed that the anti-inflammatory effect of emeheterone (3,6-dibenzyl-5-methoxy-4-oxido-1H-pyrazin-4-ium-2-one) in B. edulis was particularly significant in inflammatory bowel disease. In addition, histological analysis with periodic acid-Schiff staining confirmed that B. edulis significantly restored intestinal mucin expression in dextran sodium sulfate-induced mice, and blood metabolomics analysis revealed that B. edulis ameliorated systemic metabolic disorders induced by dextran sodium sulfate by improving tryptophan and tyrosine metabolism. In summary, B. edulis may repair the intestinal mucosal barrier by inhibiting the nuclear factor-κB signaling pathway, effectively ameliorate dextran sodium sulfate-induced metabolic disorders in mice and restore metabolic homeostasis by regulating tryptophan and tyrosine metabolism. Overall, B. edulis can be used as a natural multi-targeted intervention strategy for intestinal inflammation with potential applications in the prevention and treatment of inflammatory bowel disease, providing a theoretical basis for the development of novel intestinal health intervention programs.

Key words: Boletus edulis extract; inflammatory bowel disease; nuclear factor-κB signaling pathway; metabolomics

中图分类号: